Martin Vogelbaum, Director at Cara Therapeutics, Inc. (CARA), bought 2,668,057 shares at $11.00 ($2.5M) on 2014-02-05, disclosed to the SEC on 2014-02-05.
Open-market purchase of $2.5M CARA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,442,239 | $0 | 0.0% |
| 2 | $11.00 | 225,818 | $2.5M | 100.0% |
| Total | $0.93 avg | 2,668,057 | $2.5M | 100% |
| Filing → |
| CARA | SELL | 2020-11-19 | $97K | — | Filing → |
| CARA | BUY | 2016-03-18 | $3.9M | — | Filing → |